Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DEVICE/DRUG APPROVALS

Medical Professionals Reference (MPR)

Spravato Approved as Monotherapy for Treatment-Resistant Depression

Psychiatry February 5th 2025

MedCentral

Suzetrigine’s Approval Signals a Shift in Non-Opioid Pain Management

Anesthesiology February 3rd 2025

Oncology Learning Network

Datopotamab Deruxtecan Approved for HR-Positive, HER2-Negative Breast Cancer

Oncology, Medical January 21st 2025

Medical Professionals Reference (MPR)

Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity

Endocrinology, Diabetes, Metabolism January 8th 2025

Oncology News Central (ONC)

FDA Approves Inavolisib Combination for Advanced Breast Cancer

Oncology, Medical October 21st 2024

Medical Professionals Reference (MPR)

FDA Clears Cologuard Plus for Colorectal Cancer Screening

Family Medicine/General Practice October 16th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form